Navigation Links
Einstein to develop anti-HIV drug delivery system
Date:10/2/2009

October 2, 2009 (BRONX, NY) The National Institutes of Health has awarded Albert Einstein College of Medicine of Yeshiva University a four-year, $7.2 million grant to develop a microbicide-releasing vaginal ring to prevent HIV transmission.

"While condoms are excellent at preventing the transmission of HIV, it's often difficult for women to negotiate their use," says principal investigator Betsy C. Herold, M.D., professor of pediatrics, of microbiology & immunology, and of obstetrics & gynecology and women's health at Einstein. "It's imperative that women have alternative strategies available to protect their own health. Our belief is that an intravaginal ring that delivers a combination of drugs is the best strategy."

Vaginal rings are soft, plastic, doughnut-shaped devices designed to provide controlled release of drugs to the vagina over extended periods. At present, there are several models available for delivering contraceptives, but none for microbicides.

Dr. Herold and her colleagues will evaluate several anti-HIV microbicides, ultimately aiming for a two-drug combination. "Over the last decade, we've learned that when you expose HIV to a single drug, you make it easier to select for resistance," she says. "So, we are trying to target HIV infection at two different steps very early in its life cycle, which should prevent the establishment of any infection."

One of the drugs to be evaluated is tenofovir, which blocks reverse transcriptase, an enzyme crucial to HIV reproduction. Tenofovir is used currently as an oral systemic therapy against HIV, but it has also shown promise as a topical microbicide. The team will also test the efficacy of two so-called fusion inhibitors, including maraviroc and PIE12-trimer, which block the virus from entering target immune cells by different mechanisms.

The team will pay particular attention to choosing microbicides that preserve natural vaginal defenses against HIV.
'/>"/>

Contact: Deirdre Branley
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Einstein scientists move closer to a safer anthrax vaccine
2. Einstein researchers devise a fast and sensitive way to detect ricin
3. NIH funds research center for womens reproductive health at Einstein
4. Einstein and Pitt researchers develop new TB test that will dramatically cut diagnosis time
5. Empire State Stem Cell Board awards $12.7 million to Albert Einstein College of Medicine
6. Einstein scientists receive $10 million NIH grant
7. Einstein researchers develop technique to count messages made by single genes
8. Einstein researchers develop a new way to study how breast cancer spreads
9. In scientific first, Einstein researchers correct decline in organ function associated with old age
10. Feinstein researchers develop new genetic method and identify novel genes for schizophrenia
11. Einstein researchers receive grants totaling $700,000 for innovative breast cancer research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Einstein to develop anti-HIV drug delivery system
(Date:4/9/2015)... JOSE, Calif. , April 9, 2015 ... human interface solutions, announced today that it will report ... on Thursday, April 23, 2015, after the close of ... for analysts and investors at 2:00 p.m. PT (5:00 ...   To participate on the live call, ...
(Date:4/2/2015)... -- According to preliminary estimates Fingerprint Cards, ... than 125 MSEK. This exceeds the guidance provided by ... for Q1 2015 would be in line with the ... The operating result for the first quarter is estimated ... will as previously communicated be published on May 21. ...
(Date:3/31/2015)... YORK , March 31, 2015   Guidepoint ... the launch of the Post-Surgical Pain Management TRACKER, part ... products tracking usage trends in the medical device and ... access to data including treatment volumes, market share, and ... the pain associated with joint surgery. The ...
Breaking Biology News(10 mins):Synaptics to Report Third Quarter Results on April 23 2Fingerprint Cards Revises Revenues for Q1 2015 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3
... a negative view of climate engineering, the deliberate large-scale ... to a new study. The results are from ... (New Zealand) who have undertaken the first systematic large-scale ... The work is published in Nature Climate ...
... announced today the purchase of an Irys ™ System ... genome assembly of Aegilops tauschii, one of three progenitors ... led by Dr. Jan Dvorak , will use the Irys ... orientation of all genes and transposable elements of the A. ...
... of Nottingham have discovered a key difference in the biological ... bacterial pathogens. The study, published in the journal ... the University,s School of Life Sciences, centred on STAT1, a ... role in regulating genes in the body. STAT-1 responds ...
Cached Biology News:Climate engineering -- what do the public think? 2UC Davis Purchases Irys System From BioNano Genomics To Advance Genome Mapping And Assembly Of Wheat Relative 2UC Davis Purchases Irys System From BioNano Genomics To Advance Genome Mapping And Assembly Of Wheat Relative 3UC Davis Purchases Irys System From BioNano Genomics To Advance Genome Mapping And Assembly Of Wheat Relative 4UC Davis Purchases Irys System From BioNano Genomics To Advance Genome Mapping And Assembly Of Wheat Relative 5Research uncovers key difference between our bodies' fight against viruses and bacteria 2
(Date:5/4/2015)... Marianjoy Rehabilitation Hospital has ... hand impairments by acquiring the Armeo®Spring arm and ... site. , Secured through grant support of a ... option for patients with upper extremity weakness or ... of just four Illinois providers offering treatment with ...
(Date:5/1/2015)... , May 1, 2015 /CNW/ - Softchoice, a leading North American ... is the proud recipient of two Cisco® Partner Summit Country ... of the Year and Security Partner of the Year for ... taking place this week in Montreal . ... but two Cisco partner awards at this year,s conference," said ...
(Date:5/1/2015)... SILVER SPRING, Md. and RESEARCH TRIANGLE ... Corporation (NASDAQ: UTHR ) announced today that Roger ... Therapeutics, will provide an overview and update on the company,s ... Care Conference in Boston, Massachusetts . ... 2015, at 3:30 PM Eastern Time, and can be accessed ...
(Date:4/30/2015)... 30, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... that it has commenced an underwritten public offering of ... the underwriters a 30-day option to purchase up to ... stock offered in the public offering. The offering is ... assurance as to whether or when the offering may ...
Breaking Biology Technology:Marianjoy Acquires Armeo®Spring Arm and Hand Rehabilitation Exoskeleton at Oakbrook Terrace Facility 2Softchoice recognized with two Country Awards at Cisco Partner Summit 2015 2BioAmber Inc. Announces Public Offering Of Common Stock 2BioAmber Inc. Announces Public Offering Of Common Stock 3
... Brownstein, Art Director at CONNEXION Healthcare (CXHC), ... by the Healthcare Businesswomen,s Association (HBA). HBA ... sectors of the healthcare industry, including pharmaceutical, ... market research. Nominated by HBA,s corporate members, ...
... Calif., Feb. 18 Amgen Inc. (Nasdaq: ... Drug Administration (FDA) has accepted Amgen,s submission and filed ... RANK Ligand inhibitor. The indications for which Amgen ... postmenopausal osteoporosis (PMO) in women and treatment and prevention ...
... Speed up the Peer Review Process!COLUMBIA, S.C., ... Bulletin Board: CLXS), a leading developer of ... today that the American Association for Cancer ... Finder and Journal Dashboard applications for the ...
Cached Biology Technology:Jennifer Brownstein, of CONNEXION Healthcare, Honored as 'Rising Star' by Healthcare Businesswomen's Association 2FDA Accepts Amgen's Submission and Files Biologics License Application for Denosumab 2FDA Accepts Amgen's Submission and Files Biologics License Application for Denosumab 3FDA Accepts Amgen's Submission and Files Biologics License Application for Denosumab 4FDA Accepts Amgen's Submission and Files Biologics License Application for Denosumab 5FDA Accepts Amgen's Submission and Files Biologics License Application for Denosumab 6American Association for Cancer Research (AACR) Deploys Collexis' Reviewer Finder and Journal Dashboard Applications 2American Association for Cancer Research (AACR) Deploys Collexis' Reviewer Finder and Journal Dashboard Applications 3